Form 4 for PTCT PTC THERAPEUTICS, INC.
Accepted 2025-01-03 00:00:00 ET · period of report 2024-12-31 · accession 0001415889-25-000580 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-03 | 2024-12-31 | PTCT | Klein Matthew B. | CEO, Dir | S - Sale | $45.16 | -8,279 | 217.5K | -4% | -$373.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | S | D | 8,279 | $45.16 | 217,528 | D | — | — | (F1) Represents shares automatically sold pursuant to an irrevocable sell to cover election entered into upon acceptance of the grant to satisfy tax withholding obligations in connection with the vesting of 18,750 RSUs from a December 28, 2023 grant of 75,000 RSUs. |